Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Vitreoretinal Diseases and Surgery
What has been your experience incorporating the Port Delivery System (PDS) into clinical practice?
Related Questions
How has intraoperative OCT influenced your surgical decision-making during complex macular cases?
What factors guide the choice between early versus delayed vitrectomy after an open globe injury?
What alternative treatment strategies can be considered for pediatric patients with idiopathic choroidal neovascularization (CNVM) who require q4 week intravitreal anti-VEGF injections?
If a patient is legally blind and on hydroxychloroquine, do you still recommend follow up with ophthalmology to monitor for hydroxychloroquine retinal toxicity?
In patients with retinitis pigmentosa–associated cystoid macular edema that is refractory to medical management, does pars plana vitrectomy have a therapeutic role?
How do you manage a situation where the lens optic shifts in front of the iris after a Yamane technique?
What factors influence your evaluation of surgical candidacy for persistent fetal vasculature, and how do you approach operative management?
In what scenarios do you consider using an amniotic membrane graft for macular hole closure?
How do you approach patient selection for starting intravitreal complement inhibitors?
What clinical or OCT-based parameters guide your decision to perform an ERM peel in patients with DME and concurrent ERM?
